This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Management Associates' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Health Management Associates, Inc. (HMA)

Q1 2012 Earnings Call

April 24, 2012 11:00 am ET


John Merriwether - VP of Financial Relations

Gary Newsome - President and CEO

Kelly Curry - CFO

Bob Farnham - SVP, Finance


Adam Feinstein - Barclays Capital

Whit Mayo - Robert Baird

Gary Leiberman - Wells Fargo Securities

A.J. Rice - UBS

Kevin Fischbeck - Bank of America/Merrill Lynch

Gary Taylor - Citigroup

Ralph Giacobbe - Credit Suisse

Dana Vartabedian - Deutsche Bank

Tom Gallucci - Lazard Capital Markets



Good morning, my name is Melissa and I will be your conference operator today. At this time I would like to welcome everyone to the Health Management First Quarter 2012 Earnings Conference Call. (Operator Instructions). Thank you.

Mr. John Merriwether, Vice President of Financial Relations, you may begin your conference.

John Merriwether

Thank you, Melissa, and good morning everyone. I am John Merriwether, Vice President of Financial Relations for Health Management Associates. I would like to welcome you to Health Management's First Quarter 2012 Earnings Conference Call.

Before we get started with the call, I would like to read a disclosure statement. Statements made thought this presentation are based on current estimates of future events and the company has no obligation to update or correct these estimates. Listeners are cautioned that any such looking statements are not guarantees of future performance that involve risks and uncertainties that may and that actual results made different materially as a result of these various factors.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,777.06 +304.69 1.85%
S&P 500 1,985.89 +34.53 1.77%
NASDAQ 4,777.6030 +69.8280 1.48%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs